EUVIMEDObjevte EUVIMED
Vergleichsstudie

Gene Panel Versus Whole Exome Sequencing for Fetal Anomalies

Kate Swanson iD, Matthew A Shear, Teresa N Sparks iD, Nuriye N Sahin-Hodoglugil, Billie R Lianoglou iD, Mary E Norton

Prenatal Diagnosis · 2026-05 · 46 (5-6) · 643-649

DOI: 10.1002/pd.70118 ↗

At a glance

Vergleichsstudie in Prenatal Diagnosis, published online on 2026-03-12. Written by Kate Swanson and 5 co-authors. Institution: Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Maternal-Fetal Medicine, University of California, San Francisco, Califo…. Major MEDLINE topics: Exome Sequencing, Genetic Testing, Congenital Abnormalities, Prenatal Diagnosis. Cited 2 times so far (Crossref); 15 references. Funded by: NHGRI NIH HHS, National Human Genome Research Institute.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

Exome sequencing (ES) and gene panels can be considered for fetal anomalies. Whether ES offers substantial benefit over targeted panels is not clear.

Methods

Secondary analysis of a prospective cohort study of pregnancies with fetal anomalies undergoing ES. We included cases with isolated or multisystem skeletal dysplasias, CNS anomalies, and/or cardiac anomalies. Participants underwent ES, and pathogenic (P) and likely pathogenic (LP) variants were reported. The primary outcome was the percentage of P/LP variants found on ES that would have been identified on panels available prenatally in the United States.

Results

109 cases with relevant anomalies were included in the primary analysis. Of these, 20 (18%) had P/LP variant(s) identified on ES—4 multisystem, 4 isolated CNS, 6 isolated cardiac, and 6 isolated skeletal dysplasia. Gene panels would have detected 50 (88%) of the variants identified by ES. Yield was highest for isolated skeletal anomalies (100%) compared to CNS and cardiac malformations (75% and 67%, p = 0.02). Yield was higher for isolated anomalies than multisystem anomalies (median 91.5% vs. 50%, p < 0.01).

Conclusions

In cases of fetal anomalies with genetic etiologies identified on ES, commercial gene panels had variable diagnostic yields. Panels performed worst for multisystem anomalies.

Subjects

MeSH terms (MEDLINE)

Exome SequencingGenetic TestingCongenital AbnormalitiesPrenatal DiagnosisHumansFemalePregnancyProspective StudiesHeart Defects, CongenitalAdult

Authors and institutions

  • Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Maternal-Fetal Medicine, University of California, San Francisco, California, USA.
  • Department of Pediatrics, Division of Medical Genetics, University of California, San Francisco, California, USA.
  • Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Intermountain Healthcare, Salt Lake City, Utah, USA.
  • Center for Maternal-Fetal Precision Medicine, University of California, San Francisco, California, USA.
  • Institute for Human Genetics, University of California, San Francisco, California, USA.

ORCID profiles: Kate Swanson, Teresa N Sparks, Billie R Lianoglou

Funding

  • NHGRI NIH HHS
  • National Human Genome Research Institute

Cite

APA

Swanson, K., Shear, M. A., Sparks, T. N., Sahin-Hodoglugil, N. N., Lianoglou, B. R., & Norton, M. E. (2026). Gene Panel Versus Whole Exome Sequencing for Fetal Anomalies. Prenatal Diagnosis, 46(5-6), 643-649. https://doi.org/10.1002/pd.70118

Vancouver

Swanson K, Shear MA, Sparks TN, Sahin-Hodoglugil NN, Lianoglou BR, Norton ME. Gene Panel Versus Whole Exome Sequencing for Fetal Anomalies. Prenatal Diagnosis. 2026;46(5-6):643-649. doi:10.1002/pd.70118

BibTeX
@article{Swanson2026,
  author = {Swanson, Kate and Shear, Matthew A and Sparks, Teresa N and Sahin-Hodoglugil, Nuriye N and Lianoglou, Billie R and Norton, Mary E},
  title = {Gene Panel Versus Whole Exome Sequencing for Fetal Anomalies},
  journal = {Prenatal Diagnosis},
  year = {2026},
  volume = {46},
  number = {5-6},
  pages = {643--649},
  doi = {10.1002/pd.70118}
}
Start for free →